Michael R. Hodges

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Raoul Herbrecht, David W. Denning, Thomas F. Patterson et al. · New England Journal of Medicine · 2002 · 3.3K citations · Full text

Treatment of HCV Infection by Targeting MicroRNA

Harry L.A. Janssen, Hendrik W. Reesink, Eric Lawitz et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

Thomas J. Walsh, Irja Lutsar, Timothy Driscoll et al. · The Pediatric Infectious Disease Journal · 2002 · 435 citations

A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

R. Ally, Dirk Schürmann, Wolfgang Kreisel et al. · Clinical Infectious Diseases · 2001 · 333 citations · Full text

Diagnostic Mycology, Anti-infective Agents, Antifungal Agent +13

<i>In Vitro</i> Antiviral Activity and Preclinical and Clinical Resistance Profile of Miravirsen, a Novel Anti-Hepatitis C Virus Therapeutic Targeting the Human Factor miR-122

Søren Ottosen, Todd B. Parsley, Lu Yang et al. · Antimicrobial Agents and Chemotherapy · 2014 · 228 citations · Full text